- search results

The Irish private equity market is growing fast, with investment by venture capital firms increasing by 351 per cent since 1997. According to this annual overview by the Irish Venture Capital Association the outlook for future growth looks strong– particularly in the high-tech sector.

Corporate finance activity and private equity deal flow in France are gaining recognition in the international investment arena. Zephus outlines some of the major deals that have contributed to its increased profile.

The year 2000 was another record year for Canadian private equity says Smith Lyons LLP. And, with tax and legal changes on the horizon, 2001 looks set to be even better.

Canada's venture capital industry shattered all records in 2000. Over $6bn was invested, reflecting a 132 per cent increase on 1999. This report is a summary of the key trends for the year, by Macdonald & Associates for the Canadian Venture Capital Association

Venture capital investments continued to set new records in the US and Europe in the first half of 2000, according to this report from the Global Entrepreneurship Monitor.

Capital gains tax can have a serious impact on investment returns and subsequently affects where institutions invest their capital. The Canadian Venture Capital Association believes that budget proposals concerning capital gains, outlined in February 2000, do not go far enough to foster a competitive business environment.

A series of successful political and economic reforms mean that Poland attracts more foreign direct investment than any other country in central and eastern Europe. Here are some of the highlights from last year, provided by PAIZ.

Private equity in Canada continued to flourish in 1999, with early-stage activity showing strong growth. Capital invested reached a record high, particularly in follow-on investments according to this review by Macdonald & Associates and the CVCA.

Poland's resurgence during the 1990s has been a well-kept secret. It has attracted considerable foreign direct investment, which propelled its rapid economic growth and gave it the ability to weather the 1998 global financial crisis. These successes were the focus of a McKinsey Global Institute study in 2000.

The seventh annual European life sciences report from Ernst & Young describes the year 1999 as the ‘biotech revolution'. With many new companies springing up, advanced business models and a rush of technology, the sector has undergone a radical facelift.